COSCIENS Biopharma (CSCI) Q2 2024 Earnings

16MayConfirmed
Q2 2024
-4.74
-4.24
-3.74
-3.24

Details

Expected EPS
-3.24
Actual EPS
-4.74
Surprise EPS
-1.5
Surprise Percent
+46.3%

Description

COSCIENS Biopharma (CSCI) has reported earnings of -4.74 per share for Q2 2024.

0 Comments

Share your thoughts